Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymphotropic retrovirus in multiple sclerosis].

F Nuccetelli1, M Assetta, A Di Muzio

  • 1Università di Chieti, Clinica Neurologica.

Minerva Medica
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study.

ESMO open·2024
Same author

Transcranial direct current stimulation for Phantom Limb Pain circuitopathy: Efficacy and safety in a patient with a cardiac defibrillator.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population.

Journal of neurology, neurosurgery, and psychiatry·2015
Same author

Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2014
Same author

Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review.

Aging clinical and experimental research·2013
Same author

Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.

Current Alzheimer research·2012
Same journal

Tumor-induced osteomalacia: a 2026 update.

Minerva medica·2026
Same journal

Smoking, healthy lifestyle and adolescence.

Minerva medica·2026
Same journal

How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

Minerva medica·2026
Same journal

Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

Minerva medica·2026
Same journal

Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

Minerva medica·2026
Same journal

Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

Minerva medica·2026
See all related articles

This study investigated human T-lymphotropic viruses (HTLV) in Multiple Sclerosis (MS) patients. No evidence of anti-HTLV III antibodies was found, and only a small percentage of MS patients had anti-HTLV I antibodies.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • The etiology of Multiple Sclerosis (MS) remains incompletely understood, with viral infections being a long-standing area of investigation.
  • Retroviruses, specifically human T-lymphotropic viruses (HTLV), have been proposed as potential etiological agents in MS.
  • Previous research has explored various viral links to MS without definitive conclusions.

Purpose of the Study:

  • To investigate the presence of antibodies against human T-lymphotropic virus type I (anti-HTLV I) and human T-lymphotropic virus type III (anti-HTLV III) in patients diagnosed with Multiple Sclerosis.
  • To assess the potential role of HTLV-I and HTLV-III infections in the pathogenesis of MS.

Main Methods:

  • Serum samples were collected from 31 patients diagnosed with Multiple Sclerosis.

Related Experiment Videos

  • Enzyme-linked immunosorbent assays (ELISA) or similar serological techniques were employed to detect the presence of specific antibodies against HTLV-I and HTLV-III.
  • Antibody levels were quantified and compared against established thresholds for positivity.

    • Main Results:

    • Antibodies against human T-lymphotropic virus type I (anti-HTLV I) were detected in the serum of 3 out of 31 MS patients, representing a prevalence of 9.6%.
    • None of the 31 MS patients tested positive for antibodies against human T-lymphotropic virus type III (anti-HTLV III).
    • The findings suggest a low or absent association between HTLV-III and MS in this cohort.

    Conclusions:

    • The study found a low prevalence of anti-HTLV I antibodies among Multiple Sclerosis patients.
    • No evidence of anti-HTLV III antibodies was found in the studied MS cohort.
    • These results do not strongly support a significant etiological role for HTLV-I or HTLV-III in the development of Multiple Sclerosis based on this serological investigation.